Clinical trial
Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF): Evaluation of Radiographic and Patient Outcomes
NCT00948831 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF): Evaluation of Radiographic and Patient Outcomes
- Lead sponsor
- NuVasive
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- October 31, 2012
- Enrollment
- 51 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease, lumbar